Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

04.06.2018

1 Ann Surg
2 Ann Surg Oncol
5 Anticancer Res
5 BMC Cancer
2 Br J Cancer
5 Breast Cancer
7 Breast Cancer Res Treat
1 Cancer Cell
1 Cancer Lett
1 Cancer Res
1 Carcinogenesis
3 Clin Breast Cancer
3 Clin Cancer Res
1 Clin Exp Metastasis
3 Eur J Surg Oncol
1 Eur Radiol
1 Gene
1 J Clin Oncol
4 Lancet Oncol
1 Mod Pathol
2 NPJ Breast Cancer
2 Oncogene
2 Oncology
2 Oncology (Williston Park)
6 PLoS One



    Ann Surg

  1. OZMEN T, Lazaro M, Zhou Y, Vinyard A, et al
    Evaluation of Simplified Lymphatic Microsurgical Preventing Healing Approach (S-LYMPHA) for the Prevention of Breast Cancer-Related Clinical Lymphedema After Axillary Lymph Node Dissection.
    Ann Surg. 2018 May 23. doi: 10.1097/SLA.0000000000002827.
    >> Share


    Ann Surg Oncol

  2. MOOSSDORFF M, Nakhlis F, Hu J, Barry WT, et al
    The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy.
    Ann Surg Oncol. 2018 May 31. pii: 10.1245/s10434-018-6519.
    >> Share

  3. ONG CT, Campbell BM, Thomas SM, Greenup RA, et al
    Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.
    Ann Surg Oncol. 2018 May 31. pii: 10.1245/s10434-018-6533.
    >> Share


    Anticancer Res

  4. DANDAMUDI A, Tommie J, Nommsen-Rivers L, Couch S, et al
    Dietary Patterns and Breast Cancer Risk: A Systematic Review.
    Anticancer Res. 2018;38:3209-3222.
    >> Share

  5. CHOE MH, Kim J, Ahn J, Hwang SG, et al
    Centrosome Clustering Is a Tumor-selective Target for the Improvement of Radiotherapy in Breast Cancer Cells.
    Anticancer Res. 2018;38:3393-3400.
    >> Share

  6. LI J, Zhang J, Jin L, Deng H, et al
    Silencing lnc-ASAH2B-2 Inhibits Breast Cancer Cell Growth via the mTOR Pathway.
    Anticancer Res. 2018;38:3427-3434.
    >> Share

  7. TRESKA V, Topolcan O, Zoubkova V, Treskova I, et al
    Perioperative Tumour Marker Levels as Prognostic Factors for Surgical Treatment of Breast Cancer Liver Metastases.
    Anticancer Res. 2018;38:3647-3652.
    >> Share

  8. MALTER W, Hellmich M, Badian M, Kirn V, et al
    Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
    Anticancer Res. 2018;38:3657-3662.
    >> Share


    BMC Cancer

  9. NATTENMULLER CJ, Kriegsmann M, Sookthai D, Fortner RT, et al
    Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study.
    BMC Cancer. 2018;18:616.
    >> Share

  10. MUDDUWA L, Peiris H, Gunasekara S, Abeysiriwardhana D, et al
    KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy.
    BMC Cancer. 2018;18:589.
    >> Share

  11. HOUSE CD, Grajales V, Ozaki M, Jordan E, et al
    IKappaKappaepsilon cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.
    BMC Cancer. 2018;18:595.
    >> Share

  12. MADHU KRISHNA B, Chaudhary S, Mishra DR, Naik SK, et al
    Estrogen receptor alpha dependent regulation of estrogen related receptor beta and its role in cell cycle in breast cancer.
    BMC Cancer. 2018;18:607.
    >> Share

  13. WHITNEY J, Corredor G, Janowczyk A, Ganesan S, et al
    Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer.
    BMC Cancer. 2018;18:610.
    >> Share


    Br J Cancer

  14. WEIN L, Luen SJ, Savas P, Salgado R, et al
    Checkpoint blockade in the treatment of breast cancer: current status and future directions.
    Br J Cancer. 2018 May 29. pii: 10.1038/s41416-018-0126.
    >> Share

  15. HALKETT G, O'Connor M, Jefford M, Aranda S, et al
    RT Prepare: a radiation therapist-delivered intervention reduces psychological distress in women with breast cancer referred for radiotherapy.
    Br J Cancer. 2018 Jun 1. pii: 10.1038/s41416-018-0112.
    >> Share


    Breast Cancer

  16. LOUHICHI T, Ziadi S, Saad H, Dhiab MB, et al
    Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
    Breast Cancer. 2018 May 29. pii: 10.1007/s12282-018-0875.
    >> Share

  17. SAJI S
    The long and winding road for overcoming resistance to hormone therapy in breast cancer.
    Breast Cancer. 2018 May 28. pii: 10.1007/s12282-018-0876.
    >> Share

  18. GAO L, Li SC
    Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation.
    Breast Cancer. 2018 May 25. pii: 10.1007/s12282-018-0872.
    >> Share

  19. WEN L, Liu L, Wen L, Yu T, et al
    Artesunate promotes G2/M cell cycle arrest in MCF7 breast cancer cells through ATM activation.
    Breast Cancer. 2018 May 24. pii: 10.1007/s12282-018-0873.
    >> Share

  20. OSTAPCHUK YO, Perfilyeva YV, Kustova EA, Urazalieva NT, et al
    Functional heterogeneity of circulating T regulatory cell subsets in breast cancer patients.
    Breast Cancer. 2018 May 24. pii: 10.1007/s12282-018-0874.
    >> Share


    Breast Cancer Res Treat

  21. LIU J, Yang Y, Wang H, Wang B, et al
    Syntenin1/MDA-9 (SDCBP) induces immune evasion in triple-negative breast cancer by upregulating PD-L1.
    Breast Cancer Res Treat. 2018 May 29. pii: 10.1007/s10549-018-4833.
    >> Share

  22. JAIN S, Shah AN, Santa-Maria CA, Siziopikou K, et al
    Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy.
    Breast Cancer Res Treat. 2018 May 30. pii: 10.1007/s10549-018-4792.
    >> Share

  23. JACOB L, Scholten PC, Kostev K, Kalder M, et al
    Association between sleep disorders and the presence of breast cancer metastases in gynecological practices in Germany: a case-control study of 11,412 women.
    Breast Cancer Res Treat. 2018 May 29. pii: 10.1007/s10549-018-4831.
    >> Share

  24. LEOPOLD C, Wagner AK, Zhang F, Lu CY, et al
    Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.
    Breast Cancer Res Treat. 2018 Jun 1. pii: 10.1007/s10549-018-4819.
    >> Share

  25. WANG Z, Katsaros D, Biglia N, Shen Y, et al
    High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
    Breast Cancer Res Treat. 2018 May 29. pii: 10.1007/s10549-018-4839.
    >> Share

  26. ELMI M, Sequeira S, Azin A, Elnahas A, et al
    Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database.
    Breast Cancer Res Treat. 2018 May 28. pii: 10.1007/s10549-018-4830.
    >> Share

  27. ANDERSSON Y, Bergkvist L, Frisell J, de Boniface J, et al
    Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Breast Cancer Res Treat. 2018 May 30. pii: 10.1007/s10549-018-4820.
    >> Share


    Cancer Cell

  28. CANOVAS B, Igea A, Sartori AA, Gomis RR, et al
    Targeting p38alpha Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells.
    Cancer Cell. 2018 May 14. pii: S1535-6108(18)30181.
    >> Share


    Cancer Lett

  29. WU J, Jiang Z, Chen C, Hu Q, et al
    CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis.
    Cancer Lett. 2018;430:179-192.
    >> Share


    Cancer Res

  30. JASTRZEBSKI K, Thijssen B, Kluin RJ, de Lint K, et al
    Integrative modeling identifies key determinants of inhibitor sensitivity in breast cancer cell lines.
    Cancer Res. 2018 May 29. pii: 0008-5472.CAN-17-2698.
    >> Share


    Carcinogenesis

  31. BAK MJ, Furmanski P, Shan NL, Lee HJ, et al
    Tocopherols inhibit estrogen-induced cancer stemness and OCT4 signaling in breast cancer.
    Carcinogenesis. 2018 May 26. pii: 5004853. doi: 10.1093.
    >> Share


    Clin Breast Cancer

  32. KIM HJ, Lee MH, Lee JE, Park S, et al
    Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30019.
    >> Share

  33. DENG Y, Ma G, Li W, Wang T, et al
    CDK4/6 Inhibitors in Combination With Hormone Therapy for HR(+)/HER2(-) Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30798.
    >> Share

  34. KOZAK MM, Jacobson CE, von Eyben R, Walck E, et al
    Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30796.
    >> Share


    Clin Cancer Res

  35. ANURAG M, Punturi N, Hoog J, Bainbridge MN, et al
    Comprehensive profiling of DNA repair defects in breast cancer identifies a novel class of endocrine therapy resistance drivers.
    Clin Cancer Res. 2018 May 23. pii: 1078-0432.CCR-17-3702.
    >> Share

  36. UNNI N, Sudhan DR, Arteaga CL
    Neratinib: Inching up on the cure rate of HER2+ breast cancer?
    Clin Cancer Res. 2018 May 25. pii: 1078-0432.CCR-18-1114.
    >> Share

  37. DICKLER MN, Saura C, Richards D, Krop I, et al
    Phase II Study of Taselisib (GDC0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer.
    Clin Cancer Res. 2018 May 23. pii: 1078-0432.CCR-18-0613.
    >> Share


    Clin Exp Metastasis

  38. NATHANSON SD, Krag D, Kuerer HM, Newman LA, et al
    Breast cancer metastasis through the lympho-vascular system.
    Clin Exp Metastasis. 2018 May 23. pii: 10.1007/s10585-018-9902.
    >> Share


    Eur J Surg Oncol

  39. PAPALOUKA V, Gilbert FJ
    Inflammatory breast cancer-importance of breast imaging.
    Eur J Surg Oncol. 2018 May 16. pii: S0748-7983(18)31058.
    >> Share

  40. FENTIMAN IS
    Unmet needs of men with breast cancer.
    Eur J Surg Oncol. 2018 May 15. pii: S0748-7983(18)31054.
    >> Share

  41. ORECCHIA R
    Radiation therapy for inflammatory breast cancer.
    Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31069.
    >> Share


    Eur Radiol

  42. MALL S, Noakes J, Kossoff M, Lee W, et al
    Can digital breast tomosynthesis perform better than standard digital mammography work-up in breast cancer assessment clinic?
    Eur Radiol. 2018 May 30. pii: 10.1007/s00330-018-5473.
    >> Share


    Gene

  43. XU J, Zhang W, Tang L, Chen W, et al
    Epithelial-mesenchymal transition induced PAI-1 is associated with prognosis of triple-negative breast cancer patients.
    Gene. 2018 May 23. pii: S0378-1119(18)30586-9. doi: 10.1016/j.gene.2018.
    >> Share


    J Clin Oncol

  44. WOLFF AC, Hammond MEH, Allison KH, Harvey BE, et al
    Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
    J Clin Oncol. 2018 May 30:JCO2018778738. doi: 10.1200/JCO.2018.77.8738.
    >> Share


    Lancet Oncol

  45. MURTHY R, Borges VF, Conlin A, Chaves J, et al
    Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study.
    Lancet Oncol. 2018 May 24. pii: S1470-2045(18)30256.
    >> Share

  46. FOUKAKIS T
    Ribociclib in premenopausal women with advanced breast cancer.
    Lancet Oncol. 2018 May 24. pii: S1470-2045(18)30367.
    >> Share

  47. TRIPATHY D, Im SA, Colleoni M, Franke F, et al
    Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
    Lancet Oncol. 2018 May 24. pii: S1470-2045(18)30292.
    >> Share

  48. BURKI TK
    Responses to carboplatin in BRCA1/2-mutated breast cancer.
    Lancet Oncol. 2018 May 24. pii: S1470-2045(18)30407.
    >> Share


    Mod Pathol

  49. DILL EA, Dillon PM, Bullock TN, Mills AM, et al
    IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1.
    Mod Pathol. 2018 May 25. pii: 10.1038/s41379-018-0061.
    >> Share


    NPJ Breast Cancer

  50. SPARANO JA
    Prognostic gene expression assays in breast cancer: are two better than one?
    NPJ Breast Cancer. 2018;4:11.
    >> Share

  51. CARDOSO F, Curigliano G
    The PROMISe to increase precision in adjuvant therapy for early breast cancer: To "Type" or to "Print"?
    NPJ Breast Cancer. 2018;4:12.
    >> Share


    Oncogene

  52. SIRINIAN C, Papanastasiou AD, Schizas M, Spella M, et al
    RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-kappaB activation and EGFR signaling.
    Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0324.
    >> Share

  53. LU L, Dong J, Wang L, Xia Q, et al
    Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Oncogene. 2018 May 31. pii: 10.1038/s41388-018-0340.
    >> Share


    Oncology

  54. LANDRY S, Chasles G, Pointreau Y, Bourgeois H, et al
    Influence of an Adapted Physical Activity Program on Self-Esteem and Quality of Life of Breast Cancer Patients after Mastectomy.
    Oncology. 2018 May 30:1-4. doi: 10.1159/000489265.
    >> Share

  55. CORSO G, Maisonneuve P, Santomauro GI, De Scalzi AM, et al
    Ipsilateral Breast Tumor Reappearance and Contralateral Breast Cancer after Primary Breast Cancer Treatment: A Comprehensive Retrospective Study of 15,168 Patients.
    Oncology. 2018 May 30:1-9. doi: 10.1159/000488764.
    >> Share


    Oncology (Williston Park)

  56. SHAH M, Nunes MR, Stearns V
    CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor-Positive Advanced Breast Cancer?
    Oncology (Williston Park). 2018;32:216-22.
    >> Share

  57. BROCKWAY JP, Shapiro CL
    Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer.
    Oncology (Williston Park). 2018;32:235-7.
    >> Share


    PLoS One

  58. RAINEY L, van der Waal D, Donnelly LS, Evans DG, et al
    Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
    PLoS One. 2018;13:e0197772.
    >> Share

  59. HARALDSDOTTIR A, Torfadottir JE, Valdimarsdottir UA, Adami HO, et al
    Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    PLoS One. 2018;13:e0198017.
    >> Share

  60. GHOSH A, Sarkar S, Banerjee S, Behbod F, et al
    MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.
    PLoS One. 2018;13:e0198143.
    >> Share

  61. VEYS I, Pop CF, Barbieux R, Moreau M, et al
    ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
    PLoS One. 2018;13:e0197857.
    >> Share

  62. ALHAMAMI M, Cheng W, Lyu Y, Allen C, et al
    Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLoS One. 2018;13:e0196998.
    >> Share

  63. CRUZ-ROA A, Gilmore H, Basavanhally A, Feldman M, et al
    High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection.
    PLoS One. 2018;13:e0196828.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016